Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jan 06 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release announcing the launch of Topiramate Extended-Release Capsules. The product has received final approval from the United States Food and Drug Administration for marketing in various dosages. Zydus is the first company to launch this medication in the United States, which is indicated for epilepsy and migraine prophylaxis.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases